Edwin Rock - Net Worth and Insider Trading

Edwin Rock Net Worth

The estimated net worth of Edwin Rock is at least $268,011 dollars as of 2024-11-05. Edwin Rock is the Chief Medical Officer of GlycoMimetics Inc and owns about 680,403 shares of GlycoMimetics Inc (GLYC) stock worth over $268,011. Details can be seen in Edwin Rock's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edwin Rock has not made any transactions after 2024-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Edwin Rock

To

Edwin Rock Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edwin Rock owns 1 companies in total, including GlycoMimetics Inc (GLYC) .

Click here to see the complete history of Edwin Rock’s form 4 insider trades.

Insider Ownership Summary of Edwin Rock

Ticker Comapny Transaction Date Type of Owner
GLYC GlycoMimetics Inc 2024-06-21 Chief Medical Officer

Edwin Rock Latest Holdings Summary

Edwin Rock currently owns a total of 1 stock. Edwin Rock owns 680,403 shares of GlycoMimetics Inc (GLYC) as of June 21, 2024, with a value of $268,011.

Latest Holdings of Edwin Rock

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GLYC GlycoMimetics Inc 2024-06-21 680,403 0.39 268,011

Holding Weightings of Edwin Rock


Edwin Rock Form 4 Trading Tracker

According to the SEC Form 4 filings, Edwin Rock has made a total of 4 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 305,000 shares on June 21, 2024, which cost Edwin Rock around $79,300.

Insider Trading History of Edwin Rock

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edwin Rock Trading Performance

GuruFocus tracks the stock performance after each of Edwin Rock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edwin Rock is -1.34%. GuruFocus also compares Edwin Rock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edwin Rock within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edwin Rock's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edwin Rock

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 8.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Edwin Rock Ownership Network

Ownership Network List of Edwin Rock

No Data

Ownership Network Relation of Edwin Rock

Insider Network Chart

Edwin Rock Owned Company Details

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Edwin Rock is the Chief Medical Officer of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , CFO Brian M. Hahn , and SVP & Chief Commercial Officer Bruce S Johnson .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Edwin Rock made 2 insider transaction in GlycoMimetics Inc (GLYC) with a net purchase of 370,403. Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 13,800 shares made by Brian M. Hahn , and a net purchase of 30,000 shares made by Daniel M Junius .

In summary, during the past 3 months, insiders sold 542,616 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 542,616 shares. During the past 18 months, 2,275,199 shares of GlycoMimetics Inc (GLYC) were sold and 431,403 shares were bought by its insiders, resulting in a net sale of 1,843,796 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GlycoMimetics Inc Insider Transactions

No Available Data

Edwin Rock Mailing Address

Above is the net worth, insider trading, and ownership report for Edwin Rock. You might contact Edwin Rock via mailing address: 9708 Medical Center Drive, Rockville Md 20850.